Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Adult-type pulmonary tuberculosis in children 10-14 years of age.
Marais BJ, Gie RP, Hesseling AH, Beyers N. Marais BJ, et al. Among authors: hesseling ah. Pediatr Infect Dis J. 2005 Aug;24(8):743-4. doi: 10.1097/01.inf.0000173305.04212.09. Pediatr Infect Dis J. 2005. PMID: 16094237
Pediatric tuberculous meningitis: Model-based approach to determining optimal doses of the anti-tuberculosis drugs rifampin and levofloxacin for children.
Savic RM, Ruslami R, Hibma JE, Hesseling A, Ramachandran G, Ganiem AR, Swaminathan S, McIlleron H, Gupta A, Thakur K, van Crevel R, Aarnoutse R, Dooley KE. Savic RM, et al. Clin Pharmacol Ther. 2015 Dec;98(6):622-9. doi: 10.1002/cpt.202. Epub 2015 Oct 22. Clin Pharmacol Ther. 2015. PMID: 26260983 Free PMC article.
Differentiation of Mycobacterium tuberculosis complex by PCR amplification of genomic regions of difference.
Warren RM, Gey van Pittius NC, Barnard M, Hesseling A, Engelke E, de Kock M, Gutierrez MC, Chege GK, Victor TC, Hoal EG, van Helden PD. Warren RM, et al. Int J Tuberc Lung Dis. 2006 Jul;10(7):818-22. Int J Tuberc Lung Dis. 2006. PMID: 16850559
Prediction of delayed treatment response in pulmonary tuberculosis: use of time to positivity values of Bactec cultures.
Carroll NM, Uys P, Hesseling A, Lawrence K, Pheiffer C, Salker F, Duncan K, Beyers N, van Helden PD. Carroll NM, et al. Tuberculosis (Edinb). 2008 Nov;88(6):624-30. doi: 10.1016/ Epub 2008 May 5. Tuberculosis (Edinb). 2008. PMID: 18456556
Towards early inclusion of children in tuberculosis drugs trials: a consensus statement.
Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, Browning R, Gardiner E, Hafner R, Hesseling A, How C, Jean-Philippe P, Lessem E, Makhene M, Mbelle N, Marais B, McIlleron H, McNeeley DF, Mendel C, Murray S, Navarro E, Anyalechi EG, Porcalla AR, Powell C, Powell M, Rigaud M, Rouzier V, Samson P, Schaaf HS, Shah S, Starke J, Swaminathan S, Wobudeya E, Worrell C. Nachman S, et al. Lancet Infect Dis. 2015 Jun;15(6):711-20. doi: 10.1016/S1473-3099(15)00007-9. Epub 2015 May 6. Lancet Infect Dis. 2015. PMID: 25957923 Free PMC article. Review.
Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.
Rabie H, Decloedt EH, Garcia-Prats AJ, Cotton MF, Frigati L, Lallemant M, Hesseling A, Schaaf HS. Rabie H, et al. Expert Opin Pharmacother. 2017 Apr;18(6):589-598. doi: 10.1080/14656566.2017.1309023. Epub 2017 Mar 27. Expert Opin Pharmacother. 2017. PMID: 28346018 Review.
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Suryavanshi N, Murrill M, Gupta A, Hughes M, Hesseling A, Kim S, Naini L, Jones L, Smith B, Gupte N, Dawson R, Mave V, Meshram S, Mendoza-Ticona A, Sanchez J, Kumarasamy N, Comins K, Conradie F, Shenje J, Nerette Fontain S, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo U, Cristina Garcia Ferreira A, Okeyo E, Swindells S, Churchyard G, Shah NS. Suryavanshi N, et al. Clin Infect Dis. 2020 Jan 16;70(3):436-445. doi: 10.1093/cid/ciz254. Clin Infect Dis. 2020. PMID: 30919881 Free PMC article.
The PREVENT study to evaluate the effectiveness and acceptability of a community-based intervention to prevent childhood tuberculosis in Lesotho: study protocol for a cluster randomized controlled trial.
Hirsch-Moverman Y, Howard AA, Frederix K, Lebelo L, Hesseling A, Nachman S, Mantell JE, Lekhela T, Maama LB, El-Sadr WM. Hirsch-Moverman Y, et al. Trials. 2017 Nov 21;18(1):552. doi: 10.1186/s13063-017-2184-0. Trials. 2017. PMID: 29157275 Free PMC article. Clinical Trial.
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.
Chabala C, Turkova A, Thomason MJ, Wobudeya E, Hissar S, Mave V, van der Zalm M, Palmer M, Kapasa M, Bhavani PK, Balaji S, Raichur PA, Demers AM, Hoddinott G, Owen-Powell E, Kinikar A, Musoke P, Mulenga V, Aarnoutse R, McIlleron H, Hesseling A, Crook AM, Cotton M, Gibb DM; SHINE trial team. Chabala C, et al. Trials. 2018 Apr 19;19(1):237. doi: 10.1186/s13063-018-2608-5. Trials. 2018. PMID: 29673395 Free PMC article. Clinical Trial.
Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).
Swindells S, Gupta A, Kim S, Hughes MD, Sanchez J, Mave V, Dawson R, Kumarasamy N, Comins K, Smith B, Rustomjee R, Naini L, Shah NS, Hesseling A, Churchyard G. Swindells S, et al. Int J Tuberc Lung Dis. 2018 Sep 1;22(9):1016-1022. doi: 10.5588/ijtld.18.0163. Int J Tuberc Lung Dis. 2018. PMID: 30092866 Free PMC article. Clinical Trial.